Immix BiopharmaIMMX
13F holders, Q1 2026 (March 31)77holders +10
21new positions
12sold out
2famous investors
$9.11avg. 13F price*
At the end of Q1 2026, 77 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, up 10 from Q4 2025. 21 opened new positions and 12 sold out. The largest holders were Janus Henderson Group PLC ($43.7M), Saturn V Capital Management LP ($33.6M) and Eventide Asset Management, LLC ($23.2M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 21 | $14.1M |
| Exits | 12 | $14.5M |
All 13F filers, Q4 2025 → Q1 2026: 5,742,268 shares bought and 3,972,538 shares sold, net +1,769,730 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 77 holders
| Janus Henderson Group PLC | 0.02% | Add +22.4% | 4,802,002 | $43.7M |
| Saturn V Capital Management LP | 6.09% | Add +23.1% | 3,693,585 | $33.6M |
| Eventide Asset Management, LLC | 0.38% | No change | 2,549,019 | $23.2M |
| Vanguard Capital Management LLC | 0.00% | — | 1,787,994 | $16.3M |
| Millennium Management | 0.01% | Add +5.5% | 1,750,200 | $15.9M |
| Marshall Wace, LLP | 0.02% | Reduce -17.0% | 1,641,552 | $15.0M |
| Logos Global Management LP | 0.57% | Add +22.5% | 1,225,000 | $11.2M |
| Bleichroeder LP | 1.58% | No change | 1,000,000 | $9.1M |
| Franklin Resources Inc. | 0.00% | Reduce -1.2% | 969,066 | $8.8M |
| Velan Capital Investment Management LP | 4.22% | Add +2014.3% | 740,000 | $6.7M |
| Blue Owl Capital Holdings LP | 1.35% | Reduce -44.5% | 547,552 | $5.0M |
| Susquehanna International Group, LLP | 0.01% | Add +19.7% | 471,394 | $4.3M |
| BlackRock, Inc. | 0.00% | Add +259.6% | 468,377 | $4.3M |
| Geode Capital Management, LLC | 0.00% | Add +88.3% | 463,384 | $4.2M |
| LGT Fund Management Co Ltd. | 0.16% | Add +233.3% | 416,594 | $3.8M |
| T. Rowe Price Associates Inc. | 0.00% | New | 415,001 | $3.8M |
| Great Point Partners LLC | 0.78% | New | 350,000 | $3.2M |
| Institute for Wealth Management, LLC. | 0.33% | New | 337,552 | $3.1M |
| Burkehill Global Management, LP | 0.14% | No change | 294,118 | $2.7M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 252,914 | $2.3M |
| KVP Capital Advisors, LP | 1.57% | No change | 230,423 | $2.1M |
| J. Goldman & Co LP | 0.10% | Add +92.9% | 228,089 | $2.1M |
| State Street Corp. | 0.00% | Add +97.1% | 191,910 | $1.7M |
| Qube Research & Technologies Ltd | 0.00% | Add +276.8% | 187,675 | $1.7M |
| Sei Investments Co. | 0.00% | Add +100.0% | 147,140 | $1.3M |
| Morgan Stanley | 0.00% | Add +10.5% | 139,886 | $1.3M |
| Northern Trust Corp. | 0.00% | Add +37.3% | 138,232 | $1.3M |
| Informed Momentum Co LLC | 0.13% | No change | 120,856 | $1.1M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -54.2% | 95,404 | $869K |
| Tocqueville Asset Management L.P. | 0.01% | Add +30.6% | 89,550 | $816K |
| Bank of New York Mellon Corp | 0.00% | Reduce -15.3% | 83,611 | $762K |
| XTX Topco Ltd | 0.01% | Add +74.7% | 81,051 | $738K |
| Bridgeway Capital Management, LLC | 0.01% | New | 80,000 | $729K |
| UBS Group AG | 0.00% | Add +31.1% | 76,832 | $700K |
| United Capital Financial Advisors, LLC | 0.00% | No change | 70,682 | $644K |
| Hudson Bay Capital Management LP | 0.00% | Add +88.7% | 63,501 | $578K |
| Brevan Howard Capital Management LP | 0.01% | New | 57,508 | $524K |
| Palumbo Wealth Management LLC | 0.12% | New | 55,232 | $503K |
| TD Asset Management Inc | 0.00% | New | 53,200 | $485K |
| Barclays PLC | 0.00% | Add +47.9% | 51,768 | $472K |
| Virtu Financial LLC | 0.02% | Reduce -34.8% | 48,109 | $438K |
| Citadel Advisors | 0.00% | Reduce -37.4% | 47,173 | $430K |
| Squarepoint Ops LLC | 0.00% | Add +106.9% | 44,490 | $405K |
| Bank of America Corp. | 0.00% | Add +256968.8% | 41,131 | $375K |
| Jane Street Group, LLC | 0.00% | Reduce -79.0% | 35,164 | $320K |
| Certuity, LLC | 0.02% | New | 35,000 | $319K |
| Private Advisor Group, LLC | 0.00% | Add +9.5% | 34,725 | $316K |
| Imprint Wealth LLC | 1.30% | Add +56.2% | 31,248 | $285K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 28,964 | $264K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 27,462 | $250K |
| TritonPoint Partners, LLC | 0.08% | No change | 24,526 | $223K |
| Concurrent Investment Advisors, LLC | 0.00% | Reduce -11.6% | 24,251 | $221K |
| Mangrove Partners Im, LLC | 0.02% | New | 23,772 | $217K |
| OMERS ADMINISTRATION Corp | 0.00% | Reduce -72.7% | 20,400 | $186K |
| Vanguard Global Advisers, LLC | 0.00% | — | 19,742 | $180K |
| Fox Run Management, L.L.C. | 0.03% | New | 20,693 | $178K |
| Gsa Capital Partners LLP | 0.01% | New | 17,817 | $162K |
| Wells Fargo & Company | 0.00% | New | 17,149 | $156K |
| Diametric Capital, LP | 0.03% | New | 14,539 | $132K |
| Kera Capital Partners, Inc. | 0.01% | No change | 13,000 | $118K |
| Commonwealth Equity Services, LLC | 0.00% | Add +3.5% | 12,820 | $117K |
| EntryPoint Capital, LLC | 0.03% | New | 11,324 | $103K |
| Mathes Company, Inc. | 0.04% | No change | 10,650 | $97K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -80.0% | 10,000 | $91K |
| SBI Securities Co., Ltd. | 0.00% | No change | 10,000 | $91K |
| Snowden Capital Advisors LLC | 0.00% | No change | 10,000 | $91K |
| Allworth Financial LP | 0.00% | Add +26.8% | 7,245 | $66K |
| Simplex Trading, LLC | 0.00% | New | 4,255 | $39K |
| Osaic Holdings, Inc. | 0.00% | New | 4,000 | $36K |
| BNP Paribas Financial Markets | 0.00% | Add +2.7% | 2,774 | $25K |
| Citigroup Inc. | 0.00% | Add +24.9% | 2,464 | $22K |
| JPMorgan Chase & Co. | 0.00% | Reduce -50.3% | 2,537 | $22K |
| Cwm, LLC | 0.00% | No change | 1,000 | $9K |
| Group One Trading LLC | 0.00% | New | 879 | $8K |
| Royal Bank of Canada | 0.00% | Reduce -94.1% | 59 | $1K |
| Fortitude Family Office, LLC | 0.00% | New | 53 | $483 |
| Aspect Partners, LLC | 0.00% | New | 9 | $82 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.